{
    "id": "nclex_ngn_mc_2026_011",
    "questionType": "multipleChoice",
    "stem": "The nurse is reviewing the client's electronic health record (EHR) and is preparing to administer the scheduled 0900 medications. Based on the provided data, which action is the highest priority for the nurse to take?",
    "options": [
        {
            "label": "C",
            "content": "Request a neurology consult to evaluate the client's clonus and hyperreflexia."
        },
        {
            "label": "A",
            "content": "Withhold the scheduled dose of sertraline and notify the healthcare provider immediately."
        },
        {
            "label": "D",
            "content": "Administer the scheduled sertraline and document the client's mental status changes."
        },
        {
            "label": "B",
            "content": "Administer the PRN lorazepam for severe agitation and apply a cooling blanket."
        }
    ],
    "case": {
        "title": "54-year-old client with altered mental status",
        "tabs": [
            {
                "id": "tab1",
                "title": "Nurses' Note",
                "content": "0730: Client admitted from home with acute onset of confusion and agitation. Partner reports client has a history of major depressive disorder and migraines. Partner states, \"They seemed more depressed lately and started taking St. John's Wort from the health food store about two weeks ago because they couldn't get a timely appointment with their psychiatrist.\" On assessment, client is diaphoretic, restless, and unable to follow complex commands. Spontaneous, inducible clonus noted in both ankles. Deep tendon reflexes are +4 in lower extremities. Pupils are mydriatic."
            },
            {
                "id": "tab2",
                "title": "Vital Signs",
                "content": {
                    "type": "table",
                    "headers": [
                        "Time",
                        "Temperature",
                        "Heart Rate",
                        "Blood Pressure",
                        "Respiratory Rate",
                        "SpO2"
                    ],
                    "rows": [
                        [
                            "0730 (ED)",
                            "38.8° C (101.8° F)",
                            "128",
                            "168/94",
                            "24",
                            "96% on room air"
                        ],
                        [
                            "0800",
                            "39.4° C (102.9° F)",
                            "136",
                            "172/98",
                            "26",
                            "95% on room air"
                        ],
                        [
                            "0830",
                            "40.1° C (104.2° F)",
                            "142",
                            "180/102",
                            "28",
                            "94% on room air"
                        ]
                    ]
                }
            },
            {
                "id": "tab3",
                "title": "Laboratory Results",
                "content": {
                    "type": "table",
                    "headers": [
                        "Test",
                        "Result",
                        "Reference Range"
                    ],
                    "rows": [
                        [
                            "Sodium",
                            "140 mEq/L",
                            "135-145 mEq/L"
                        ],
                        [
                            "Potassium",
                            "4.1 mEq/L",
                            "3.5-5.0 mEq/L"
                        ],
                        [
                            "BUN",
                            "22 mg/dL",
                            "10-20 mg/dL"
                        ],
                        [
                            "Creatinine",
                            "1.3 mg/dL",
                            "0.6-1.2 mg/dL"
                        ],
                        [
                            "Creatine Kinase (CK)",
                            "2,800 U/L",
                            "30-200 U/L"
                        ],
                        [
                            "Lactate, Venous",
                            "3.1 mmol/L",
                            "0.5-2.2 mmol/L"
                        ]
                    ]
                }
            },
            {
                "id": "tab4",
                "title": "Medication Administration Record (MAR)",
                "content": {
                    "type": "table",
                    "headers": [
                        "Medication",
                        "Dose",
                        "Route",
                        "Frequency",
                        "Notes"
                    ],
                    "rows": [
                        [
                            "Sertraline",
                            "100 mg",
                            "PO",
                            "Daily at 0900",
                            "For major depressive disorder"
                        ],
                        [
                            "Sumatriptan",
                            "50 mg",
                            "PO",
                            "PRN for migraine",
                            "Last dose yesterday evening"
                        ],
                        [
                            "Lorazepam",
                            "2 mg",
                            "IV",
                            "PRN every 4 hrs for severe agitation",
                            "Available to give"
                        ]
                    ]
                }
            }
        ]
    },
    "rationale": {
        "correct": "The client's clinical presentation is a classic triad for Serotonin Syndrome, a life-threatening condition caused by excessive serotonergic activity in the central nervous system. The data shows: 1) mental status changes (confusion, agitation), 2) autonomic hyperactivity (hyperthermia, tachycardia, hypertension, diaphoresis), and 3) neuromuscular abnormalities (hyperreflexia, clonus). The MAR reveals multiple serotonergic agents: sertraline (SSRI), sumatriptan (triptan), and the client-reported St. John's Wort (an herbal supplement with SSRI-like properties). The laboratory results (elevated CK and lactate) indicate severe muscle breakdown (rhabdomyolysis) and metabolic acidosis, which are serious complications. The absolute highest priority is to stop the causative agents. Administering another dose of sertraline would worsen the toxicity and could lead to seizures, multi-organ failure, and death. Therefore, withholding the medication and immediately notifying the provider is the critical safety action.",
        "incorrect": "The incorrect options represent actions that either fail to address the root cause of the life-threatening syndrome, are secondary in priority, or are actively harmful. The core of this question tests the ability to recognize a critical contraindication and take immediate action to prevent further harm.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "Withhold the scheduled dose of sertraline and notify the healthcare provider immediately.",
                "isCorrect": true,
                "justification": "This is the correct 'SAFETY STOP' action. Recognizing the constellation of symptoms as Serotonin Syndrome, the nurse must immediately cease administration of all serotonergic agents to prevent worsening toxicity. Notifying the provider is essential for initiating further treatment, such as benzodiazepines for agitation/rigidity and potentially cyproheptadine as an antidote."
            },
            {
                "label": "B",
                "content": "Administer the PRN lorazepam for severe agitation and apply a cooling blanket.",
                "isCorrect": false,
                "justification": "This action is unsafe because it fails to address the primary problem. While benzodiazepines (like lorazepam) and cooling measures are treatments for Serotonin Syndrome, they are secondary interventions. The absolute first priority is source control: stopping the offending medications. Proceeding with treatment without first withholding the sertraline is a critical error."
            },
            {
                "label": "C",
                "content": "Request a neurology consult to evaluate the client's clonus and hyperreflexia.",
                "isCorrect": false,
                "justification": "This action is incorrect because it dangerously delays life-saving intervention. While a neurologist might eventually be consulted, the signs and symptoms point clearly to a medication-induced toxicity that requires immediate action by the nurse and primary provider, not a specialty consult. The situation is too acute for this delay."
            },
            {
                "label": "D",
                "content": "Administer the scheduled sertraline and document the client's mental status changes.",
                "isCorrect": false,
                "justification": "This is the most dangerous option. Administering more of the causative agent would be catastrophic, accelerating the progression of Serotonin Syndrome towards severe hyperthermia, rhabdomyolysis, seizures, and cardiovascular collapse. This action demonstrates a failure to recognize a life-threatening contraindication."
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyzing",
        "cjmmStep": "Take Actions",
        "nclexCategory": "Reduction of Risk Potential",
        "nclexSubcategory": "Potential for Complications of Diagnostic Tests/Treatments/Procedures",
        "difficulty": "Level 5",
        "topicTags": [
            "Serotonin Syndrome",
            "Medication Safety",
            "Adverse Effects",
            "Contraindications",
            "Pharmacology",
            "Critical Thinking",
            "Health Equity",
            "Social Determinants of Health"
        ]
    }
}